Table 2 Differential expressed metabolites in HR-NB vs. LIR-NB in negative mode.

From: Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastoma

NO

Metabolites

Mass-to-charge ratio

Retention time (min)

VIP value

Fold Change

P value

Regu-lation

1

2-Hydroxyhexadecanoic acid

272.23615

20.27

1.4007

0.733

0.0492

Down

2

Stearic acid

284.2728

28.83

1.8609

0.920

0.023

Down

3

PE(20:2(11Z,14Z)/0:0)

505.3176

12.9

1.6675

0.885

0.0447

Down

4

Glu Gly Ile Pro Pro

511.2616

9.53

2.0426

0.622

0.0050

Down

5

LysoPE(22:5(7Z,10Z,

13Z,16Z,19Z)/0:0)

527.302

13.82

1.4399

1.306

0.0390

Up

6

Glu His His Ser

554.2058

25.96

2.7679

2.076

0.0004

Up

7

Thr Cys Glu Pro Ile

561.2453

8.75

2.0784

0.458

0.0037

Down

8

Leu Met Trp Met

579.2559

8.73

1.8149

0.401

0.0263

Down

9

Ile Arg Asn Trp

587.3225

12

1.9417

1.468

0.0427

Up

10

Trp Arg Arg Pro

613.338

12.81

2.0587

0.780

0.0181

Down

11

PG(P-16:0/12:0)

650.4494

23.25

1.1894

0.886

0.0307

Down

12

Met Arg Trp Trp

677.31265

13.52

2.1581

0.758

0.0343

Down

13

1'-Hydroxy-γ-carotene glucoside

762.506

20.83

2.1192

2.182

0.0041

Up

Back to article page